Cdk5 as a Drug Target for the Treatment of Alzheimer’s Disease

By Lau Lit-Fui   Seymour Patricia A.   Sanner Mark A.   Schachter Joel B.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 267-274

Humana Press, Inc

Access to resources Recommend Favorite

The AICD Interacting Protein DAB1 is Up-Regulated in Alzheimer Frontal Cortex Brain Samples and Causes Deregulation of Proteins Involved in Gene Expression Changes

By  

Current Alzheimer Research, Vol. 8, Iss. 5, 2011-08 ,pp. : 573-582

Bentham Science Publishers

Access to resources Recommend Favorite

Apolipoprotein C-I Expression in the Brain in Alzheimer's Disease

By Petit-Turcotte C.   Stohl S.M.   Beffert U.   Cohn J.S.   Aumont N.   Tremblay M.   Dea D.   Yang L.   Poirier J.   Shachter N.S.  

Neurobiology of Disease, Vol. 8, Iss. 6, 2001-12 ,pp. : 953-963

Elsevier

Access to resources Recommend Favorite

Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer’s disease

By  

Current Alzheimer Research, Vol. 12, Iss. 8, 2015-01 ,pp. : 745-751

Bentham Science Publishers

Access to resources Recommend Favorite

Addressing the complex etiology of Alzheimer’’s disease: the role of p25/Cdk5

By Mungenast Alison E   Tsai Li-Huei  

Future Neurology, Vol. 6, Iss. 4, 2011-07 ,pp. : 481-496

Future Medicine

Access to resources Recommend Favorite